TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.

Edith A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.